Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bile Duct Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02082522
What this trial is testing

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Who this might be right for
Hilar Cholangiocarcinoma
Concordia Laboratories Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT04645160
What this trial is testing

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Who this might be right for
CholangiocarcinomaBile Duct NeoplasmBiliary Tract Malignancy
National Cancer Institute (NCI) 31
Not applicableStudy completedNCT03766035
What this trial is testing

Cholangioscopy in Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Primary Sclerosing Cholangitis (PSC)
Boston Scientific Corporation 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04238637
What this trial is testing

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)

Who this might be right for
Intrahepatic Cholangiocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 50
Testing effectiveness (Phase 2)UnknownNCT00356161
What this trial is testing

HAI Via Interventionally Implanted Port Catheter Systems

Who this might be right for
Colorectal CancerLiver NeoplasmsHepatocellular Carcinoma+2 more
Charite University, Berlin, Germany 100
Testing effectiveness (Phase 2)Looking for participantsNCT07030140
What this trial is testing

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaHilar CholangiocarcinomaBile Duct Cancer
Jinbo Yue 38
Not applicableUnknownNCT05519605
What this trial is testing

Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD

Who this might be right for
Pancreatic CancerCholangiocarcinomaBiliary Obstruction
Radboud University Medical Center 61
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Ended earlyNCT04076761
What this trial is testing

Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaBile Duct Cancer
Sunnybrook Health Sciences Centre 8
Early research (Phase 1)Study completedNCT00987766
What this trial is testing

Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+3 more
Vanderbilt-Ingram Cancer Center 28
Post-approval studies (Phase 4)Study completedNCT02027311
What this trial is testing

Etomidate vs. Midazolam for Sedation During ERCP

Who this might be right for
CholedocholithiasisCholangiocarcinomaPancreatitis+1 more
Cheju Halla General Hospital 63
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableNot Yet RecruitingNCT07558304
What this trial is testing

Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)

Who this might be right for
CholangiocarcinomaBile Duct NeoplasmsMalignant Biliary Obstruction
Hospital de Clinicas de Porto Alegre 84
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Not applicableUnknownNCT02503384
What this trial is testing

Clinical and Basic Study for Pediatric Liver Transplantation

Who this might be right for
Biliary AtresiaMetabolic DisordersFulminant Liver Failure+1 more
RenJi Hospital 180
Testing effectiveness (Phase 2)Study completedNCT00009893
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 42
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Early research (Phase 1)Ended earlyNCT06336148
What this trial is testing

A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Actym Therapeutics, Inc. 10
Testing effectiveness (Phase 2)UnknownNCT03603834
What this trial is testing

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Khon Kaen University 25
Next Page